Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the BoardClimb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board GlobeNewswire
||
WELLESLEY, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointment of Douglas E. Williams, Ph.D., as Climb Bio’s Chair of its Board... 
First Watch to Acquire 16 Franchise Restaurants in North and South CarolinaFirst Watch to Acquire 16 Franchise Restaurants in North and South Carolina GlobeNewswire
||
Acquisition will mark second largest franchisee deal in First Watch’s history, Includes development rights for market BRADENTON, Fla., Nov. 11, 2024 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc.... 
Qlik’s Accelerating Growth Attracts Significant Investment from Thoma Bravo and ADIAQlik’s Accelerating Growth Attracts Significant Investment from Thoma Bravo and ADIA GlobeNewswire
||
Investment underscores Qlik’s market leadership and value in delivering end-to-end data integration, data quality, analytics, and AI solutions SAN FRANCISCO and PHILADELPHIA, Nov. 11, 2024 (GLOBE NEWSWIRE) — Thoma... 
Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201 GlobeNewswire
||
BOSTON, Nov. 11, 2024 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced that... 
Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO MeetingChimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting GlobeNewswire
||
DURHAM, N.C., Nov. 11, 2024 (GLOBE NEWSWIRE) — Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of... 
Tecnoglass to Attend the Baird 2024 Global Industrial ConferenceTecnoglass to Attend the Baird 2024 Global Industrial Conference GlobeNewswire
||
Miami, FL, Nov. 11, 2024 (GLOBE NEWSWIRE) — Tecnoglass, Inc. (NYSE: TGLS) (“Tecnoglass” or the “Company”), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global... 
Medicenna Announces Positive Single-Agent Activity of MDNA11 from Dose Expansion Cohort and Encouraging Safety Profile in Combination with KEYTRUDA® (pembrolizumab) at the 39th Annual Meeting of SITCMedicenna Announces Positive Single-Agent Activity of MDNA11 from Dose Expansion Cohort and Encouraging Safety Profile in Combination with KEYTRUDA® (pembrolizumab) at the 39th Annual Meeting of SITC GlobeNewswire
||
Single-agent MDNA11 shows a 30% objective response rate (3 of 10) in the monotherapy dose expansion cohort among patients with advanced and/or metastatic solid tumors who had disease progression... 
Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual MeetingBeyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting GlobeNewswire
||
– LV UNO in combination with anti-rPD-L1 resulted in prolonged survival and doubled the tumor growth inhibition rate in MAT B III tumor bearing rats compared to anti-rPD-L1 alone... SkyPeople Training Expands International Reach with New Dublin Base
||
SkyPeople Training, a specialist in aviation training, is setting its sights on further international expansion with the opening of a new base in Dublin. This development follows approval from... Lendlease Global Commercial REIT Achieves 11.4%(1) Retail Rental Reversion in 1Q FY2025Lendlease Global Commercial REIT Achieves 11.4%(1) Retail Rental Reversion in 1Q FY2025 GlobeNewswire
||
Key Highlights Portfolio occupancy improved to 89.5% with new leases committed for Building 3 of Sky Complex.Retail tenant retention rate remains healthy at 90.0%.Approximately 70% of borrowings are hedged...